Contribution of decreased expression of Ku70 to enhanced radiosensitivity by sodium butyrate in glioblastoma cell line (U251)

Abstract

The present study investigated the enhanced radiosensitivity of U-251 cells induced by sodium butyrate (NaB) and its possible mechanisms. Increased radiosensitivity of U251 cells was examined by clonogenic cell survival assays. The expression of Ku70 mRNA and protein was detected by using RT-PCR and Western blotting respectively. γ-H2AX foci were measured at different time points after ionizing irradiation alone or combined with NaB treatment. The results showed that cell survival rate was significantly reduced, both D0 and Dq values were decreased (D0: 1.43 Gy vs. 1.76 Gy; Dq: 1.22 Gy vs. 2.05 Gy) after the combined treatment as compared with irradiation alone, and sensitivity enhancing ratio (SER) reached 1.23. The average number of γ-H2AX foci per cell receiving the combined treatment was significantly increased at different time points, and the expression levels of Ku70 mRNA and protein were suppressed by NaB in a dose-dependent manner. It was concluded that enhanced radiosensitivity induced by NaB involves an inhibited expression of Ku70 and an increase in γ-H2AX foci, which suggests decreased ability in DSB repair.

Keywords

sodium butyrate / radiosensitivity / Ku70 / DNA double-strand breaks / γ-H2AX

References

[1] Van MeirE.G., HadjipanayisC.G., NordenA.D., et al.. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin, 2010, 60(3): 166-193

[2] MunshiA., TanakaT., HobbsM.L., et al.. Vorinostat, a his-tone deacetylase inhibitor, enhances the response of hu-man tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther, 2006, 5(8): 1967-1974

[3] GengL., CuneoK.C., FuA., et al.. Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cyto-plasm in irradiated non-small cell lung cancer. Cancer Res, 2006, 66(23): 11298-11304

[4] KwonH.K., AhnS.H., ParkS.H., et al.. A novel gamma-lactam-based histone deacetylase inhibitor potently inhibits the growth of human breast and renal cancer cells. Biol Pharm Bull, 2009, 32(10): 1723-1727

[5] Entin-MeerM., YangX., VandenBergS.R., et al.. In vivo efficacy of a novel histone deacetylase inhibitor in com-bination with radiation for the treatment of gliomas. Neuro Oncol, 2007, 9(2): 82-88

[6] AbbasA., GuptaS.. The role of histone deacetylases in prostate cancer. Epigenetics, 2008, 3(6): 300-309

[7] GrunsteinM.. Histone acetylation in chromatin structure and transcription. Nature, 1997, 389(6649): 349-352

[8] StruhlK.. Histone acetylation and transcriptional regula-tory mechanisms. Genes Dev, 1998, 12(5): 599-606

[9] KimY.B., KiS.W., YoshidaM., et al.. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. J Antibiot (Tokyo), 2000, 53(10): 1191-1200

[10] MaiA., MassaS., RotiliD., et al.. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med Res Rev, 2005, 25(3): 261-309

[11] GibsonP.R.. The intracellular target of butyrate’s actions: HDAC or HDON’T?. Gut, 2000, 46(4): 447-448

[12] MunshiA., KurlandJ.F., NishikawaT., et al.. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res, 2005, 11(13): 4912-4922

[13] ArundelC.M., GlicksmanA.S., LeithJ.T.. Enhancement of radiation injury in human colon tumor cells by the matu-rational agent sodium butyrate (NaB). Radiat Res, 1985, 104(3): 443-448

[14] Fernandez-CapetilloO., ChenH.T., CelesteA., et al.. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol, 2002, 4(12): 993-997

[15] RussoA.L., KwonH.C., BurganW.E., et al.. In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016. Clin Cancer Res, 2009, 15(2): 607-612

[16] JoachimiakR., KaznicaA., DrewaT.. Influence of sodium butyrate on hepatocellular carcinoma (hepG2) and glioblastoma (C6) cell lines in vitro. Acta Pol Pharm, 2007, 64(6): 561-563

[17] LouisM., RosatoR.R., BraultL., et al.. The histone deace-tylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int J Oncol, 2004, 25(6): 1701-1711

[18] WangL., LuoH.S., XiaH.. Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mito-chondrial pathway. J Int Med Res, 2009, 37(3): 803-811

[19] LitvakD.A., HwangK.O., EversB.M., et al.. Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res, 2000, 20(2A): 779-784

[20] ToyookaT., IbukiY.. Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair. Cancer Res, 2009, 69(8): 3492-3500

[21] WeiZ.L., ZhaoQ.L., YuD.Y., et al.. Enhancement of sodium butyrate-induced cell death and apoptosis by X-irradiation in the human colorectal cancer cell line HCT 116. Oncol Rep, 2008, 20(2): 397-403

[22] AdimoolamS., SirisawadM., ChenJ., et al.. HDAC inhibi-tor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A, 2007, 104(49): 19482-19487

[23] ZhangY., CarrT., DimtchevA., et al.. Attenuated DNA damage repair by trichostatin A through BRCA1 suppression. Radiat Res, 2007, 168(1): 115-124

[24] ZhangF., ZhangT., TengZ.H., et al.. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. Cancer Biol Ther, 2009, 8(9): 823-831

[25] MarksP.A., RichonV.M., BreslowR., et al.. Histone deace-tylase inhibitors as new cancer drugs. Curr Opin Oncol, 2001, 13(6): 477-483

[26] ChenJ.S., FallerD.V.. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol, 2005, 202(1): 87-99

[27] BanuelosC.A., BanathJ.P., MacPhailS.H., et al.. Radiosensitization by the histone deacetylase inhibitor PCI-24781. Clin Cancer Res, 2007, 13(22Pt1): 6816-6826

[28] FrewA.J., JohnstoneR.W., BoldenJ.E.. Enhancing the apop-totic and therapeutic effects of HDAC inhibitors. Cancer Lett, 2009, 280(2): 125-133

[29] OliveP.L.. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat Res, 1998, 150(5Suppl): S42-51

[30] KomuroY., WatanabeT., HosoiY., et al.. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer, 2002, 95(6): 1199-1205

[31] WilsonC.R., DavidsonS.E., MargisonG.P., et al.. Expression of Ku70 correlates with survival in carcinoma of the cer-vix. Br J Cancer, 2000, 83(12): 1702-1706

[32] ZhaoH.J., HosoiY., MiyachiH., et al.. DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin Cancer Res, 2000, 6(3): 1073-1078

[33] Vaganay-JueryS., MullerC., MarangoniE., et al.. De-creased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer, 2000, 83(4): 514-518

[34] OmoriS., TakiguchiY., SudaA., et al.. Suppression of a DNA double-strand break repair gene, Ku70, increases radio- and chemosensitivity in a human lung carcinoma cell line. DNA Repair (Amst), 2002, 1(4): 299-310

[35] PodhoreckaM.. Gamma H2AX in the recognition of DNA double-strand breaks. Postepy Hig Med Dosw (Online), 2009, 63: 92-98

[36] SedelnikovaO.A., RogakouE.P., PanyutinI.G., et al.. Quan-titative detection of (125)IdU-induced DNA dou-ble-strand breaks with gamma-H2AX antibody. Radiat Res, 2002, 158(4): 486-492

[37] RothkammK., LobrichM.. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA, 2003, 100(9): 5057-5062

[38] BanathJ.P., MacphailS.H., OliveP.L.. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res, 2004, 64(19): 7144-7149

[39] MacPhailS.H., BanathJ.P., YuT.Y., et al.. Expression of phosphorylated histone H2AX in cultured cell lines fol-lowing exposure to X-rays. Int J Radiat Biol, 2003, 79(5): 351-358

[40] SvetlovaM.P., SolovjevaL.V., TomilinN.V.. Mechanism of elimination of phosphorylated histone H2AX from chro-matin after repair of DNA double-strand breaks. Mutat Res, 2010, 685(1–2): 54-60

[41] KuribayashiT., OharaM., SoraS., et al.. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation. Int J Mol Med, 2010, 25(1): 25-29

[42] KimI.A., KimI.H., KimH.J., et al.. HDAC inhibi-tor-mediated radiosensitization in human carcinoma cells: a general phenomenon?. J Radiat Res (Tokyo), 2010, 51(3): 257-263